Malaria clinical trials

Explore recruiting malaria clinical trials.

Recruiting malaria studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malaria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Antimalarial prophylactic efficacy of a weekly dose atovaquone-proguanil

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Coadministration of GA2 Sporozoites With Adjuvants (CoGA)

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Late immunity following single immunization with GA2 sporozoites (GACHA)

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Durability of protection after single immunisation with genetically attenuated Plasmodium falciparum ∆mei2 (GA2) sporozoites – a follow-up, controlled human malaria rechallenge study

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Multiple Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-7602 in Healthy Participants

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Malaria trials by city

Malaria in Toronto Malaria in Vancouver Malaria in Montreal Malaria in Calgary Malaria in Edmonton Malaria in Ottawa Malaria in Winnipeg Malaria in Quebec City Malaria in Hamilton Malaria in Kitchener Malaria in London Malaria in Halifax Malaria in New York Malaria in Los Angeles Malaria in Chicago Malaria in Houston

Malaria clinical trials

Recruiting malaria studies right now

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria

Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases.

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria

Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria

Monoclonal Antibodies in Children With Severe Anaemia or Severe Malaria to Prevent Malaria After Hospital Discharge

Seasonal R21 Mass Vaccination for Malaria Elimination

FocaL Mass Drug Administration for Vivax Malaria Elimination

Dose Finding Trial of R21/Matrix-M in School Children

An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older

Also recruiting in Europe

Antimalarial prophylactic efficacy of a weekly dose atovaquone-proguanil

Coadministration of GA2 Sporozoites With Adjuvants (CoGA)

Late immunity following single immunization with GA2 sporozoites (GACHA)

A study investigating the safety, tolerability, metabolism, and elimination of INE963, a new compound in the treatment of malaria.

Durability of protection after single immunisation with genetically attenuated Plasmodium falciparum ∆mei2 (GA2) sporozoites – a follow-up, controlled human malaria rechallenge study

A Multiple Ascending Dose Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-7602 in Healthy Participants

Malaria trials by city

Other conditions